CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation
Authors:
- Szu Yu Jenny ChenSCSzu Yu Jenny Chen
- William H. SchubachWSWilliam H. Schubach
Open Access
- 1 June 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (11) , 6067-6072
Abstract
Substitution mutagenesis of EBNA2 shows that its interaction with hSNF5/Ini1 involves two sites (286IPP and DQQ313), and a mutation at a CKII phosphorylation site (SS469) is essential for the interaction. An alanine substitution (SS469AA) prevents binding to EBNA2 and diminishes the growth-promotion potential of EBNA2 in the transcomplementation assay.Keywords
This publication has 58 references indexed in Scilit:
- Expression of Transcription Factor AML-2 (RUNX3, CBFα-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation PhenotypeJournal of Virology, 2002
- The Conserved Mynd Domain of BS69 Binds Cellular and Oncoviral Proteins through a Common PXLXP MotifJournal of Biological Chemistry, 2002
- Notch1IC Partially Replaces EBNA2 Function in B Cells Immortalized by Epstein-Barr VirusJournal of Virology, 2001
- Three-dimensional structure of the tyrosine kinase c-SrcNature, 1997
- Regulation of Epstein—Barr virus latency by latent membrane protein 2Trends in Microbiology, 1996
- Mediation of Epstein-Barr Virus EBNA2 Transactivation by Recombination Signal-Binding Protein J κScience, 1994
- Epstein‐barr virus (EBV) nuclear‐antigen‐2‐induced up‐regulation of cd21 and cd23 molecules is dependent on a permissive cellular contextInternational Journal of Cancer, 1993
- Phosphorylation of the epstein-barr virus nuclear antigen 2Biochemical and Biophysical Research Communications, 1992
- Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein‐Barr virus (EBV)International Journal of Cancer, 1990
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989